Valuation: Abbott India Limited

Capitalization 58TCr 610.92Cr 521.73Cr 478.03Cr 451.92Cr 836.85Cr 841.18Cr 5.69TCr 2.22TCr 28TCr 2.29TCr 2.24TCr 96TCr P/E ratio 2026
35.5x
P/E ratio 2027 * 34.3x
Enterprise value 57TCr 592.55Cr 506.04Cr 463.65Cr 438.33Cr 811.68Cr 815.88Cr 5.52TCr 2.15TCr 27TCr 2.22TCr 2.18TCr 94TCr EV / Sales 2026
7.95x
EV / Sales 2027 * 7.46x
Free-Float
24.45%
Yield 2026 *
1.84%
Yield 2027 * 2.34%
1 day+0.93%
1 week+4.64%
Current month+8.20%
1 month+6.96%
3 months+3.95%
6 months-6.90%
Current year-5.35%
1 week 26,343
Extreme 26343
28,054.6
1 month 25,164
Extreme 25164
28,054.6
Current year 25,164
Extreme 25164
28,600
1 year 25,164
Extreme 25164
35,921.55
3 years 20,594.25
Extreme 20594.25
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 14/06/2025
Director of Finance/CFO 52 06/05/2025
Director of Finance/CFO - 01/04/2025
Director TitleAgeSince
Chairman 83 01/01/1968
Director/Board Member 69 01/03/2011
Director/Board Member 70 01/04/2019
Change 5d. change 1-year change 3-years change Capi.($)
+0.93%+4.64%-9.56%+29.75% 605.27Cr
-0.80%+2.91%+40.21%+130.90% 91TCr
+0.08%+3.59%+57.49%+44.47% 55TCr
+1.40%+4.36%+19.23%+44.32% 37TCr
-0.94%-2.05%+21.74%+10.73% 33TCr
-0.19%+3.20%+37.10%+14.50% 29TCr
+0.78%+1.00%+29.63%+26.23% 28TCr
-0.17%+0.64%+53.83%-2.88% 28TCr
+0.91%+2.12%-31.78%-49.10% 21TCr
+0.28%+2.39%+28.47%+44.28% 18TCr
Average +0.23%+1.34%+24.64%+29.32% 34.04TCr
Weighted average by Cap. -0.03%+1.25%+33.85%+50.50%

Financials

2026 2027 *
Net sales 6.92TCr 72Cr 62Cr 57Cr 53Cr 99Cr 100Cr 673.44Cr 262.17Cr 3.28TCr 271.21Cr 265.52Cr 11TCr 7.51TCr 79Cr 67Cr 61Cr 58Cr 107.55Cr 108.11Cr 731.56Cr 284.8Cr 3.57TCr 294.61Cr 288.43Cr 12TCr
Net income 1.56TCr 16Cr 14Cr 13Cr 12Cr 22Cr 22Cr 151.98Cr 59Cr 740.84Cr 61Cr 60Cr 2.57TCr 1.7TCr 18Cr 15Cr 14Cr 13Cr 24Cr 25Cr 165.87Cr 65Cr 808.56Cr 67Cr 65Cr 2.81TCr
Net Debt -1.76TCr -18Cr -16Cr -14Cr -14Cr -25Cr -25Cr -171.19Cr -67Cr -834.5Cr -69Cr -67Cr -2.9TCr -2.39TCr -25Cr -21Cr -20Cr -18Cr -34Cr -34Cr -232.25Cr -90Cr -1.13TCr -94Cr -92Cr -3.93TCr
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,659
Date Price Change Volume
14/26/14 27,515.60 +0.93% 653
13/26/13 27,261.25 +1.35% 21,736
12/26/12 26,898.10 -3.16% 5,648
11/26/11 27,776.95 +4.18% 3,864
08/26/08 26,661.45 -0.12% 1,329
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 500488 Stock